Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.88 USD | +9.21% |
|
-5.88% | +113.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/16/01 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Megan Boston
CMP | Compliance Officer | 52 | 01/16/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 01/13/01 |
Edward Smith
BRD | Director/Board Member | 53 | 14/20/14 |
Peter Francis
BRD | Director/Board Member | 68 | 01/06/01 |
Jerel Banks
CEO | Chief Executive Officer | 49 | 01/16/01 |
Megan Boston
CMP | Compliance Officer | 52 | 01/16/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,367,485 | 8,497,929 ( 90.72 %) | 0 | 90.72 % |
Company contact information
![address Benitec Biopharma Inc.(BNTC)](https://cdn.zonebourse.com/static/address/23292438.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.00% | 6.44Cr | |
+34.14% | 5.11TCr | |
-6.54% | 3.94TCr | |
+34.92% | 3.85TCr | |
+12.62% | 2.64TCr | |
-12.11% | 2.62TCr | |
-13.43% | 2.1TCr | |
+43.73% | 1.4TCr | |
+31.81% | 1.25TCr | |
-4.54% | 1.16TCr |
- Stock Market
- Equities
- BNTC Stock
- Company Benitec Biopharma Inc.